157 related articles for article (PubMed ID: 31864799)
1. Discovery of indane propanamides as potent and selective TRPV1 antagonists.
Ahn S; Kim YS; Kim MS; Ann J; Ha H; Yoo YD; Kim YH; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2020 Feb; 30(3):126838. PubMed ID: 31864799
[TBL] [Abstract][Full Text] [Related]
2. 4-Aminophenyl acetamides and propanamides as potent transient receptor potential vanilloid 1 (TRPV1) ligands.
Kim C; Ann J; Lee S; Kim E; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem; 2018 Aug; 26(15):4509-4517. PubMed ID: 30078610
[TBL] [Abstract][Full Text] [Related]
3. 2-(Halogenated Phenyl) acetamides and propanamides as potent TRPV1 antagonists.
Kang JM; Kwon SO; Ann J; Lee S; Kim C; Do N; Jeong JJ; Blumberg PM; Ha H; Vu TNL; Yoon S; Choi S; Frank-Foltyn R; Lesch B; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2021 Sep; 48():128266. PubMed ID: 34273488
[TBL] [Abstract][Full Text] [Related]
4. TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides.
Ha TH; Ryu H; Kim SE; Kim HS; Ann J; Tran PT; Hoang VH; Son K; Cui M; Choi S; Blumberg PM; Frank R; Bahrenberg G; Schiene K; Christoph T; Frormann S; Lee J
Bioorg Med Chem; 2013 Nov; 21(21):6657-64. PubMed ID: 24035514
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 2-(3,5-difluoro-4-methylsulfonaminophenyl)propanamides as potent TRPV1 antagonists.
Kim C; Ann J; Lee S; Sun W; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2018 Aug; 28(14):2539-2542. PubMed ID: 29884534
[TBL] [Abstract][Full Text] [Related]
6. Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.
Ann J; Jung A; Kim MY; Kim HM; Ryu H; Kim S; Kang DW; Hong S; Cui M; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem; 2015 Nov; 23(21):6844-54. PubMed ID: 26474664
[TBL] [Abstract][Full Text] [Related]
7. Pyridine C-region analogs of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.
Ryu H; Seo S; Lee JY; Ha TH; Lee S; Jung A; Ann J; Kim SE; Yoon S; Hong M; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Schiene K; Stockhausen H; Christoph T; Frormann S; Lee J
Eur J Med Chem; 2015 Mar; 93():101-8. PubMed ID: 25659771
[TBL] [Abstract][Full Text] [Related]
8. t-Butyl pyridine and phenyl C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.
Lee S; Kang DW; Ryu H; Kim C; Ann J; Lee H; Kim E; Hong S; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem; 2017 Apr; 25(8):2451-2462. PubMed ID: 28314510
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists.
Yan L; Wang J; Pan M; Qiu Q; Huang W; Qian H
Chem Biol Drug Des; 2016 Feb; 87(2):306-11. PubMed ID: 26360809
[TBL] [Abstract][Full Text] [Related]
10. 2-Aryl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists.
Ryu H; Seo S; Kim MS; Kim MY; Kim HS; Ann J; Tran PT; Hoang VH; Byun J; Cui M; Son K; Sharma PK; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Koegel BY; Christoph T; Frormann S; Lee J
Bioorg Med Chem Lett; 2014 Aug; 24(16):4044-7. PubMed ID: 25011915
[TBL] [Abstract][Full Text] [Related]
11. α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonists.
Tran PT; Kim HS; Ann J; Kim SE; Kim C; Hong M; Hoang VH; Ngo VT; Hong S; Cui M; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2015 Jun; 25(11):2326-30. PubMed ID: 25937016
[TBL] [Abstract][Full Text] [Related]
12. 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists.
Ryu H; Seo S; Cho SH; Kim HS; Jung A; Kang DW; Son K; Cui M; Hong SH; Sharma PK; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Schiene K; Christoph T; Frormann S; Lee J
Bioorg Med Chem Lett; 2014 Aug; 24(16):4039-43. PubMed ID: 24948568
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent transient receptor potential vanilloid 1 antagonists: design and synthesis of phenoxyacetamide derivatives.
Takahashi E; Hirano N; Nagahara T; Yoshikawa S; Momen S; Yokokawa H; Hayashi R
Bioorg Med Chem Lett; 2013 Jun; 23(11):3154-6. PubMed ID: 23632270
[TBL] [Abstract][Full Text] [Related]
14. 2-Sulfonamidopyridine C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.
Ann J; Ki Y; Yoon S; Kim MS; Lee JU; Kim C; Lee S; Jung A; Baek J; Hong S; Choi S; Pearce LV; Esch TE; Turcios NA; Lewin NE; Ogunjirin AE; Herold BK; McCall AK; Blumberg PM; Lee J
Bioorg Med Chem; 2016 Mar; 24(6):1231-40. PubMed ID: 26860926
[TBL] [Abstract][Full Text] [Related]
15. 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.
Kim MS; Ryu H; Kang DW; Cho SH; Seo S; Park YS; Kim MY; Kwak EJ; Kim YS; Bhondwe RS; Kim HS; Park SG; Son K; Choi S; DeAndrea-Lazarus IA; Pearce LV; Blumberg PM; Frank R; Bahrenberg G; Stockhausen H; Kögel BY; Schiene K; Christoph T; Lee J
J Med Chem; 2012 Oct; 55(19):8392-408. PubMed ID: 22957803
[TBL] [Abstract][Full Text] [Related]
16. 2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-region.
Thorat SA; Kang DW; Ryu H; Kim MS; Kim HS; Ann J; Ha T; Kim SE; Son K; Choi S; Blumberg PM; Frank R; Bahrenberg G; Schiene K; Christoph T; Lee J
Eur J Med Chem; 2013 Jun; 64():589-602. PubMed ID: 23685943
[TBL] [Abstract][Full Text] [Related]
17. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
[TBL] [Abstract][Full Text] [Related]
18. Phenylquinoline transient receptor potential vanilloid 1 antagonists for the treatment of pain: Discovery of 1-(2-phenylquinoline-4-carbonyl)-N-(4-(trifluoromethyl)phenyl)pyrrolidine-3-carboxamide.
Liao C; Liu Y; Liu C; Zhou J; Li H; Wang N; Li J; Liu T; Ghaleb H; Huang W; Qian H
Bioorg Med Chem; 2018 Feb; 26(4):845-854. PubMed ID: 29317149
[TBL] [Abstract][Full Text] [Related]
19. Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.
Lee S; Kim C; Ann J; Thorat SA; Kim E; Park J; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2017 Sep; 27(18):4383-4388. PubMed ID: 28838698
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists.
Li J; Nie C; Qiao Y; Hu J; Li Q; Wang Q; Pu X; Yan L; Qian H
Eur J Med Chem; 2019 Sep; 178():433-445. PubMed ID: 31202991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]